{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:54:35Z","timestamp":1781848475637,"version":"3.54.5"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Traditional pharmaco-electroencephalography (EEG) studies have mainly examined the effects of psychotropic medications at the level of individual drugs or broad drug classes, limiting biological specificity and clinical translation. This study aimed to determine whether modeling EEG spectral power changes according to the engagement of distinct neurotransmitter systems provides a more mechanistic understanding of psychotropic drug effects in a real-world clinical population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 4,128 EEG sessions from 2,083 patients in the Temple University Hospital EEG Corpus, a large heterogeneous dataset. EEG data were preprocessed and segmented into canonical frequency bands (delta, theta, alpha, beta, and gamma). Psychotropic medication data were systematically extracted and coded at the receptor level for serotonin, dopamine, norepinephrine, histamine, and acetylcholine systems using the Neuroscience-based Nomenclature framework. Receptor profiles were summarized to represent each patient\u2019s overall neurotransmitter engagement (agonistic, neutral, antagonistic, or mixed). Linear mixed-effects models were applied to assess relationships between neurotransmitter profiles and log-transformed spectral power while controlling for electrode location and patient-level variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Frequency- and region-specific EEG patterns were identified across neurotransmitter systems. Dopamine antagonists were associated with higher delta and theta power at central electrode locations and lower alpha power at occipital and temporal locations, whereas dopamine agonists were associated with higher delta activity at occipital locations and increased frontal gamma power. Serotonin antagonists showed associations with elevated slow-wave and alpha power, while serotonin agonists were linked to increased frontal alpha, decreased occipital alpha, and enhanced temporal gamma power. Both norepinephrine antagonists and agonists showed positive relationships with delta power, with a broader topographical pattern for antagonists. Theta power was positively associated with norepinephrine antagonists and negatively associated with norepinephrine agonists. Norepinephrine antagonists were related to lower temporal alpha and higher frontal and parietal gamma power. Histamine antagonists and mixed histaminergic agents were associated with lower delta, theta, and alpha power. Acetylcholine antagonists were linked to higher delta, theta, and alpha power across electrode locations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Modeling psychotropic medication effects on EEG at the neurotransmitter receptor level offers a biologically grounded and clinically relevant improvement over traditional drug class-based approaches. This neurotransmitter-centric framework enhances mechanistic interpretability and may support the development of EEG biomarkers for personalized, mechanism-based psychiatric care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2026.1737357","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:46:15Z","timestamp":1781847975000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A computational pipeline for a neurotransmitter-centric analysis of the effects of psychiatric medication on EEG spectral power"],"prefix":"10.3389","volume":"17","author":[{"given":"Samar Samy","family":"Zekerallah","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Alexandra","family":"Maxion","sequence":"additional","affiliation":[{"name":"Joint Research Center for Computational Biomedicine, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]},{"name":"Scientific Center for Neuropathic Pain Aachen, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Zweerings","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Teucher","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]},{"name":"Center for Human Genetics and Genomic Medicine, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Mathiak","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Kutafina","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Informatics, Faculty of Medicine and University Hospital Cologne, University of Cologne","place":["Cologne, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnim Johannes","family":"Gaebler","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]},{"name":"Institute for Neurophysiology, Faculty of Medicine, RWTH Aachen University","place":["Aachen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2016.10.002","article-title":"Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of major depressive disorder","volume":"84","author":"Leuchter","year":"2017","journal-title":"J Psychiatr Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00196","article-title":"The Temple University Hospital EEG data corpus","volume":"10","author":"Obeid","year":"2016","journal-title":"Front Neurosci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1055\/s-2007-1017125","article-title":"Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry","volume":"20","author":"Saletu","year":"1987","journal-title":"Pharmacopsychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2024.108319","article-title":"Spectral changes in electroencephalography linked to neuroactive medications: A computational pipeline for data mining and analysis","volume":"255","author":"Maxion","year":"2024","journal-title":"Comput Methods Programs BioMed"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116452","article-title":"Unraveling antipsychotic induced weight gain in schizophrenia - a proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychotics","volume":"348","author":"Sudar","year":"2025","journal-title":"Psychiatry Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1999.tb00365.x","article-title":"Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects","volume":"13","author":"Patat","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2774","article-title":"Abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116642903","article-title":"Neuroscience-based nomenclature (NbN) for journal of psychopharmacology","volume":"30","author":"Nutt","year":"2016","journal-title":"J Psychopharmacol"},{"key":"B9","article-title":"Chapter six - selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders","volume-title":"Advances in pharmacology","author":"Teal","year":"2019"},{"key":"B10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00023210-199605050-00007","article-title":"Mirtazapine","volume":"5","author":"Davis","year":"1996","journal-title":"CNS Drugs"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5414\/cp201484","article-title":"Electroencephalogram-based pharmacodynamic measures: a review","volume":"50","author":"Bewernitz","year":"2012","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2016.07.002","article-title":"An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice","volume":"25","author":"Salahudeen","year":"2017","journal-title":"Saudi Pharm J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1198\/016214504000001880","article-title":"Causal inference using potential outcomes: design, modeling, decisions","volume":"100","author":"Rubin","year":"2005","journal-title":"J Am Stat Assoc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0098858818789429","article-title":"Real-world data analytics fit for regulatory decision-making","volume":"44","author":"Schneeweiss","year":"2018","journal-title":"Am J Law Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Software"},{"key":"B16","unstructured":"emmeans: Estimated marginal means, aka least-squares means_\n          \n          \n            \n              R. L\n            \n          \n          \n          2023"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevE.63.021903","article-title":"Prediction of electroencephalographic spectra from neurophysiology","volume":"63","author":"Robinson","year":"2001","journal-title":"Phys Rev E"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0924-977X(90)90011-X","article-title":"C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment","volume":"1","author":"Galderisi","year":"1990","journal-title":"Eur Neuropsychopharmacol"},{"key":"B19","first-page":"249","article-title":"Development and critical evaluation of an objective procedure for the electroencephalographic classification of psychotropic drugs","volume-title":"Electroencephalography in drug research","author":"Herrmann","year":"1982"},{"key":"B20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0028-1094591","article-title":"Development of a classification rule for four clinical therapeutic psychotropic drug classes with EEG power-spectrum variables of human volunteers","volume":"12","author":"Herrmann","year":"1979","journal-title":"Pharmakopsychiatr Neuropsychopharmakol"},{"key":"B21","article-title":"The significance of pharmacodynamic measurements in the assessment of bioavailability and bioequivalence of psychotropic drugs using CEEG and dynamic brain mapping","author":"Itil","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1365-2125.1990.tb05444.x","article-title":"A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers","volume":"30","author":"McClelland","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(00)94456-0","article-title":"P01.49 Low dose amisulpride: Some evidence for alertness-increasing properties in EEG studies","volume":"15","author":"Legangneux","year":"2000","journal-title":"Eur Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(92)90077-G","article-title":"Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve","volume":"42","author":"Czobor","year":"1992","journal-title":"Psychiatry Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051003","article-title":"Pharmacokinetic-pharmacodynamic modeling of risperidone effects on electroencephalography in healthy volunteers","volume":"144","author":"Lee","year":"1999","journal-title":"Psychopharmacology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0924-977X(90)90007-W","article-title":"EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms: Comparative studies with remoxipride\/haloperidol","volume":"1","author":"Saletu","year":"1990","journal-title":"Eur Neuropsychopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017283","article-title":"Quantitative EEG, SPEM, and psychometric studies in schizophrenics before and during differential neuroleptic therapy","volume":"19","author":"Saletu","year":"1986","journal-title":"Pharmacopsychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/(SICI)1099-1077(199701\/02)12:1<75::AID-HUP840>3.0.CO;2-H","article-title":"Positive symptoms of schizophrenia: Response to haloperidol and remoxipride is associated with increased alpha EEG activity","volume":"12","author":"Moore","year":"1997","journal-title":"Hum Psychopharmacol - Clin Exp"},{"key":"B29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1176\/jnp.11.2.190","article-title":"Conventional and quantitative electroencephalography in psychiatry","volume":"11","author":"Hughes","year":"1999","journal-title":"JNP"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0128-y","article-title":"The effects of bupropion on cognitive functions in healthy subjects","volume":"182","author":"Siepmann","year":"2005","journal-title":"Psychopharmacology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0167-8760(92)90078-P","article-title":"Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment","volume":"13","author":"Kemali","year":"1992","journal-title":"Int J Psychophysiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13080","article-title":"Dopamine improves low gamma activities in the dorsal striatum of haloperidol-induced motor impairment mice","volume":"37","author":"Reakkamnuan","year":"2023","journal-title":"In Vivo"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2015.11.009","article-title":"Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson\u2019s disease","volume":"86","author":"Dupre","year":"2016","journal-title":"Neurobiol Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2021.19.2.313","article-title":"Quantitative resting state electroencephalography in patients with schizophrenia spectrum disorders treated with strict monotherapy using atypical antipsychotics","volume":"19","author":"Ozaki","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/BF00606656","article-title":"The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects","volume":"31","author":"Lader","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.1993.tb00080.x","article-title":"Changes in EEG power density of NREM sleep in depressed patients during treatment with citalopram","volume":"2","author":"Van Bemmel","year":"1993","journal-title":"J Sleep Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jad.2024.09.081","article-title":"Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic review","volume":"368","author":"Le","year":"2025","journal-title":"J Affect Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.9758\/cpn.2011.9.2.78","article-title":"Effects of psychotropic drugs on quantitative EEG among patients with schizophrenia-spectrum disorders","volume":"9","author":"Hyun","year":"2011","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0327(01)00308-1","article-title":"EEG correlates of acute and chronic paroxetine treatment in depression","volume":"69","author":"Knott","year":"2002","journal-title":"J Affect Disord"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(96)00013-7","article-title":"Citalopram: differential sleep\/wake and EEG power spectrum effects after single dose and chronic administration","volume":"79","author":"Neckelmann","year":"1996","journal-title":"Behav Brain Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108881","article-title":"Serotonin 1A receptor agonist modulation of motor deficits and cortical oscillations by NMDA receptor interaction in parkinsonian rats","volume":"203","author":"Jiang","year":"2022","journal-title":"Neuropharmacology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2019.09.039","article-title":"Effects of vortioxetine and escitalopram on electroencephalographic recordings \u2013 a randomized, crossover trial in healthy males","volume":"424","author":"Nissen","year":"2020","journal-title":"Neuroscience"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2009.08.003","article-title":"Acute atomoxetine effects on the EEG of children with attention-deficit\/hyperactivity disorder","volume":"57","author":"Barry","year":"2009","journal-title":"Neuropharmacology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90158-3","article-title":"Clomipramine and EEG sleep in depression","volume":"30","author":"Kupfer","year":"1989","journal-title":"Psychiatry Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"102009","DOI":"10.1016\/j.jchemneu.2019.01.002","article-title":"Distinct regional patterns in noradrenergic innervation of the rat prefrontal cortex","volume":"96","author":"Cerpa","year":"2019","journal-title":"J Chem Neuroanat"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2022.895481","article-title":"Probing the structure and function of locus coeruleus projections to CNS motor centers","volume":"16","author":"Waterhouse","year":"2022","journal-title":"Front Neural Circuits"},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.brainres.2015.11.022","article-title":"Evidence for a specialized role of the locus coeruleus noradrenergic system in cortical circuitries and behavioral operations","volume":"1641","author":"Chandler","year":"2016","journal-title":"Brain Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2021.08.008","article-title":"Noradrenergic profile of hippocampal formation theta rhythm in anaesthetized rats","volume":"473","author":"Broncel","year":"2021","journal-title":"Neuroscience"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100791","article-title":"The effects of reboxetine on autonomic and cognitive functions in healthy volunteers","volume":"157","author":"Siepmann","year":"2001","journal-title":"Psychopharmacol (Berl)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2013.08.028","article-title":"Bidirectional modulation of hippocampal gamma (20\u201380 Hz) frequency activity in vitro via alpha(\u03b1)- and beta(\u03b2)-adrenergic receptors (AR)","volume":"253","author":"Haggerty","year":"2013","journal-title":"Neuroscience"},{"key":"B51","first-page":"18","article-title":"Eeg-effects of promethazine. study on 17 patients (author\u2019s transl)","volume":"29","author":"Pichlmayr","year":"1980","journal-title":"Anaesthesist"},{"key":"B52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2007.08.020","article-title":"Effects of histamine H1 receptor antagonists on hippocampal theta rhythm during spatial memory performance in rats","volume":"576","author":"Masuoka","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00393.x","article-title":"Scopolamine model of dementia: electroencephalogram findings and cognitive performance","volume":"28","author":"Ebert","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975186727","article-title":"Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers","volume":"18","author":"Sagal\u00e9s","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90246-v","article-title":"Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory","volume":"31","author":"Sloan","year":"1992","journal-title":"Biol Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207969","article-title":"TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys","volume":"14","author":"Kurimoto","year":"2019","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-023-06450-3","article-title":"Pharmaco-EEG analysis of ligands varying in selectivity for \u03b11 subunit-containing GABAA receptors during the active phase in rats","volume":"240","author":"Reeves-Darby","year":"2023","journal-title":"Psychopharmacol (Berl)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00213-007-0737-8","article-title":"A pharmaco-EEG study on antipsychotic drugs in healthy volunteers","volume":"191","author":"Yoshimura","year":"2007","journal-title":"Psychopharmacology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41537-023-00419-z","article-title":"Pharmaco-EEG of antipsychotic treatment response: a systematic review","volume":"9","author":"De Pieri","year":"2023","journal-title":"Schizophr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41398-022-01796-2","article-title":"EEG as a translational biomarker and outcome measure in fragile X syndrome","volume":"12","author":"Kenny","year":"2022","journal-title":"Transl Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1549976","article-title":"Psychotherapy Research Domain Criteria: functional mechanisms of treatment and a basic theory of the mind","volume":"16","author":"Rohlfing","year":"2025","journal-title":"Front Psychiatry"},{"key":"B62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0269881109106926","article-title":"Neuroethical issues in cognitive enhancement","volume":"25","author":"Sahakian","year":"2011","journal-title":"J Psychopharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2018.00521","article-title":"EEG frequency bands in psychiatric disorders: A review of resting state studies","volume":"12","author":"Newson","year":"2019","journal-title":"Front Hum Neurosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04492-9","article-title":"Reproducible brain-wide association studies require thousands of individuals","volume":"603","author":"Marek","year":"2022","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-022-01186-3","article-title":"Mapping neurotransmitter systems to the structural and functional organization of the human neocortex","volume":"25","author":"Hansen","year":"2022","journal-title":"Nat Neurosci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf8332","article-title":"In vivo mapping of pharmacologically induced functional reorganization onto the human brain\u2019s neurotransmitter landscape","volume":"9","author":"Luppi","year":"2023","journal-title":"Sci Adv"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.17700","article-title":"Negative control outcomes","volume":"316","author":"Arnold","year":"2016","journal-title":"JAMA"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2017.04.011","article-title":"Neural oscillations demonstrate that general anesthesia and sedative states are neurophysiologically distinct from sleep","volume":"44","author":"Akeju","year":"2017","journal-title":"Curr Opin Neurobiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-020-01820-3","article-title":"An updated introduction to electroencephalogram-based brain monitoring during intended general anesthesia","volume":"67","author":"Hight","year":"2020","journal-title":"Can J Anesth\/J Can Anesth"},{"key":"B72","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrn3475-c3","article-title":"Small sample size is not the real problem","volume":"14","author":"Bacchetti","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.01067","article-title":"The influence of sample size on parameter estimates in three-level random-effects models","volume":"10","author":"Kerkhoff","year":"2019","journal-title":"Front Psychol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.tics.2024.03.010","article-title":"Beta: bursts of cognition","volume":"28","author":"Lundqvist","year":"2024","journal-title":"Trends Cognit Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00383","article-title":"Alpha- and beta-band oscillations subserve different processes in reactive control of limb movements","volume":"8","author":"Pani","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1586075","article-title":"Neural oscillations induced by gamma sensory entrainment in cognitive biotype of depression","volume":"16","author":"Shi","year":"2025","journal-title":"Front Psychiatry"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2025.08.016","article-title":"Predicting the longitudinal efficacy of medication for depression using electroencephalography and machine learning","author":"Huang","year":"2025","journal-title":"J Psychiatr Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3565(25)24740-1","article-title":"Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity","volume":"257","author":"Mandema","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.12701\/jyms.2024.00668","article-title":"Advances, challenges, and prospects of electroencephalography-based biomarkers for psychiatric disorders: a narrative review","volume":"41","author":"Yun","year":"2024","journal-title":"J Yeungnam Med Sci"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1737357\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:46:18Z","timestamp":1781847978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2026.1737357\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":79,"alternative-id":["10.3389\/fpsyt.2026.1737357"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2026.1737357","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1737357"}}